twitter Tweet

May 16: OHSU scientist to discuss TB, HIV vaccine research, clinical trials

MEDIA ALERT: Klaus Früh, Ph.D., to present at Society of Physician Entrepreneurs chapter meeting



OHSU’s Klaus Früh, Ph.D., a professor at OHSU’s Vaccine & Gene Therapy Institute, will discuss his work in developing tuberculosis and HIV vaccines based on the cytomegalovirus, as well as share efforts by OHSU spinoff Vir Biotechnology to bring those vaccines to human clinical trials a meeting of the Portland chapter of the Society of Physician Entrepreneurs.

Dan Ladizinsky, M.D., co-founder and CEO of SUTUREGARD™ Medical will provide a biotech startup pitch on SUTUREGARD™, which allows surgeons to extend their scope of practice and simply close wounds that would otherwise require skin grafts, flaps or prolonged wound care.


6 to 7 p.m., Thursday, May 16, 2019


Robertson Life Sciences Building, 2730 S.W. Moody Ave., Portland, OR 97201


More information about this free event is available on the SoPE website.


Previous Story PDX Skincare Festival unites health care, skincare to reduce melanoma mortality statewide Next Story ‘What is funding pancreatic cancer research, Alex?’: Oregon 'Jeopardy! Teen Tournament' finalist donates to OHSU
Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services